mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |